Search results
Oct 12, 2021 · At the COVID-19 pandemic's first peak, amid confusion and conflicted messaging from some news and political sources, English-language audiences flocked to science fiction.
The COVID-19 pandemic in Vietnam has resulted in 11,624,000 confirmed cases of COVID-19 and 43,206 deaths. The number of confirmed cases is the highest total in Southeast Asia, and the 13th highest in the world.
- 43,206
- Vietnam
The number of confirmed cases is lower than the true number of infections – this is due to limited testing. In a separate post we discuss how models of COVID-19 help us estimate the true number of infections. → We provide more detail on these points in our page on Cases of COVID-19.
- Hannah Ritchie, Edouard Mathieu, Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Esteban Ortiz-...
- 2020
The 78th World Science Fiction Convention ( Worldcon ), also known as CoNZealand, was held from 29 July to 2 August 2020. It was planned to be held at the TSB Arena and Shed 6, Intercontinental Hotel, Michael Fowler Center, in Wellington, New Zealand.
- 29 July – 2 August 2020
- New Zealand
- virtual / telepresence
- Science fiction
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2.The first known case was identified in Wuhan, China, in December 2019. Most scientists believe the SARS-CoV-2 virus entered into human populations through natural zoonosis, similar to the SARS-CoV-1 and MERS-CoV outbreaks, and consistent with other pandemics in human history.
- 6,960,770 (reported), 17.6–31.4 million (estimated)
- SARS-CoV-2
- 2–14 days (typically 5), after infection
- Symptomatic and supportive
Oct 12, 2021 · The pandemic highlighted appalling social inequalities: socioeconomic status was, in wealthier nations, a key risk factor for becoming ill and dying from COVID-19. In short, good science and technology cannot compensate for failures of governance, management, or social justice.
The COVID‐19 events were the catalyst needed to align in vitro, in silico, in vivo, and regulatory science in highly coordinated ways to answer urgent questions. These approaches must now be considered the new “best practice” for all medicines and vaccine development moving forward.
